Literature DB >> 24801478

Pharmacokinetics of sevoflurane elimination from respiratory gas and blood after coronary artery bypass grafting surgery.

Chih-Cherng Lu1, Lin Tso-Chou, Che-Hao Hsu, Chien-Song Tsai, Michael J Sheen, Oliver Yao-Pu Hu, Shung-Tai Ho.   

Abstract

PURPOSE: Sevoflurane, with a relative low blood-gas partition coefficient, is an ideal anesthetic to achieve rapid offset and recovery from general anesthesia. This study will determine the profiles of four concentration-time curves to characterize the pharmacokinetics of sevoflurane elimination.
METHODS: Eight patients (aged 54-76 years) undergoing coronary arterial bypass grafting surgery were enrolled in this study. At the end of surgery, anesthetic gas and blood were sampled 20 min before and after stopping sevoflurane administration, with prior maintenance of a fixed 5% inspired sevoflurane (CIsev) in 6 L/min oxygen flow for 60 min before the cessation of sevoflurane administration for the subsequent 20 min elimination. An infrared analyzer was used to determine both CIsev and end-tidal sevoflurane (CEsev). The sevoflurane concentrations in the internal jugular-bulb (Jsev), arterial (Asev) and pulmonary arterial blood (PAsev) were analyzed by gas chromatography, and cardiac output was measured using an Opti-Q pulmonary artery catheter.
RESULTS: A bi-exponential decay function was the best fit for the CEsev,Jsev, Asev, and PAsev time curves. There were two distinct components, the initial 5-min fast or distribution phase and the subsequent 15-min slow or elimination phase. Before cessation of the sevoflurane supplement, the step-down concentration of sevoflurane was listed in the following order: CIsev > CEsev > Asev ≧ Jsev > PAsev. During the elimination phase, the fastest decay occurred in CEsev, followed by Jsev, Asev and PAsev. Therefore, a reverse step-down pattern was observed (PAsev > Asev ≧ Jsev > CEsev) after 20 min. The ratio of Asev to CEsev was 89% at baseline before stopping sevoflurane administration, but the ratio of Asev to CEsev increased to 128% at the twentieth min of the sevoflurane elimination phase.
CONCLUSIONS: During elimination, the initial washout of sevoflurane from the functional residual capacity of the lungs was reflected in the fast component of the CEsev, Jsev, Asev, and PAsev time curves. In contrast, the slow component was dominated by the tangible effects of the physiological membrane barriers, such as the alveoli-pulmonary capillary and blood-brain barriers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24801478     DOI: 10.1007/s00540-014-1841-7

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  15 in total

1.  Pharmacokinetic-pharmacodynamic modeling the hypnotic effect of sevoflurane using the spectral entropy of the electroencephalogram.

Authors:  Ian D H McKay; Logan J Voss; James W Sleigh; John P Barnard; Ewa K Johannsen
Journal:  Anesth Analg       Date:  2006-01       Impact factor: 5.108

2.  Comparison of percutaneous losses of sevoflurane and isoflurane in humans.

Authors:  S H Lockhart; N Yasuda; N Peterson; M Laster; S Taheri; R B Weiskopf; E I Eger
Journal:  Anesth Analg       Date:  1991-02       Impact factor: 5.108

3.  Comparison of kinetics of sevoflurane and isoflurane in humans.

Authors:  N Yasuda; S H Lockhart; E I Eger; R B Weiskopf; J Liu; M Laster; S Taheri; N A Peterson
Journal:  Anesth Analg       Date:  1991-03       Impact factor: 5.108

4.  Solubility of I-653, sevoflurane, isoflurane, and halothane in human tissues.

Authors:  N Yasuda; A G Targ; E I Eger
Journal:  Anesth Analg       Date:  1989-09       Impact factor: 5.108

5.  Cerebral awakening concentration of sevoflurane and isoflurane predicted during slow and fast alveolar washout.

Authors:  T Katoh; Y Suguro; T Kimura; K Ikeda
Journal:  Anesth Analg       Date:  1993-11       Impact factor: 5.108

6.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

7.  Pharmacokinetics of desflurane elimination from respiratory gas and blood during the 20 minutes after cardiac surgery.

Authors:  Chih-Cherng Lu; Chien-Sung Tsai; Oliver Yao-Pu Hu; Ruei-Ming Chen; Ta-Liang Chen; Shung-Tai Ho; Tong-Joo Gan
Journal:  J Formos Med Assoc       Date:  2012-05-20       Impact factor: 3.282

8.  Pharmacokinetics of sevoflurane uptake into the brain and body.

Authors:  C C Lu; C S Tsai; S T Ho; W Y Chen; C S Wong; J J Wang; O Y P Hu; C Y Lin
Journal:  Anaesthesia       Date:  2003-10       Impact factor: 6.955

9.  Predicted sevoflurane partial pressure in the brain with an uptake and distribution model comparison with the measured value in internal jugular vein blood.

Authors:  M Nakamura; Y Sanjo; K Ikeda
Journal:  J Clin Monit Comput       Date:  1999-07       Impact factor: 2.502

10.  Pharmacokinetics of isoflurane in human blood.

Authors:  Chih-Cherng Lu; Chien-Song Tsai; Oliver Yao-Pu Hu; Ruei-Ming Chen; Ta-Liang Chen; Shung-Tai Ho
Journal:  Pharmacology       Date:  2008-04-03       Impact factor: 2.547

View more
  2 in total

1.  Arterial blood and end-tidal concentrations of sevoflurane during the emergence from anesthesia in gynecologic patients.

Authors:  Tso-Chou Lin; Chih-Cherng Lu; Che-Hao Hsu; Her-Young Su; Meei-Shyuan Lee; Shung-Tai Ho
Journal:  Clinics (Sao Paulo)       Date:  2015-03-01       Impact factor: 2.365

2.  Awakening arterial blood and end-tidal concentrations of isoflurane in female surgical patients.

Authors:  Tso-Chou Lin; Chih-Cherng Lu; Che-Hao Hsu; Joseph V Pergolizz; Cheng-Chang Chang; Meei-Shyuan Lee; Shung-Tai Ho
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.